| Methods |
Randomized, parallel, double‐blind, placebo (sham)‐
controlled study. |
| Participants |
N=20;
Geographic region: Canada
Mean age: 45.3
Discontinuations/Not available to follow‐up: none reported |
| Interventions |
Transurethral microwave hyperthermia (TUMT) (n=10) 45‐60C vs. sham (n=10).
Study duration: 1 hr session each. |
| Outcomes |
Symptomatic changes, quality of life score, American Urological Association index, prostatitis symptom frequency and severity; subjective global assessment; adverse events. |
| Notes |
|
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment (selection bias) |
Unclear risk |
B ‐ Unclear |
